Patents by Inventor Prasanth Reddy Nyalapatla

Prasanth Reddy Nyalapatla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tricyclic P2-ligand containing potent HIV-protease inhibitors against HIV/AIDS
    Patent number: 11390630
    Abstract: Various embodiments relate to a compound of the formula (I) and (II), wherein X, X1, X2, X3, and R1-R4 are defined herein, as well as pharmaceutical compositions comprising compounds of the formula (I) and/or (II) and methods of treating an HIV infection comprising administering a therapeutically effective amount of one or more compounds of formula (I) and/or (II), or a pharmaceutical composition comprising compounds of the formula (I) and/or (II), to a patient in need thereof.
    Type: Grant
    Filed: May 4, 2021
    Date of Patent: July 19, 2022
    Assignee: Purdue Research Foundation
    Inventors: Arun K. Ghosh, Hiroaki Mitsuya, Prasanth Reddy Nyalapatla
  • TRICYCLIC P2-LIGAND CONTAINING POTENT HIV-PROTEASE INHIBITORS AGAINST HIV/AIDS
    Publication number: 20210261563
    Abstract: Various embodiments relate to a compound of the formula (I) and (II), wherein X, X1, X2, X3, and R1-R4 am defined herein, as well as pharmaceutical compositions comprising compounds of the formula (I) and/or (II) and methods of treating an HIV infection comprising administering a therapeutically effective amount of one or more compounds of formula (I) and/or (II), or a pharmaceutical composition comprising compounds of the formula (I) and/or (II), to a patient in need thereof.
    Type: Application
    Filed: May 4, 2021
    Publication date: August 26, 2021
    Inventors: Arun K. Ghosh, Hiroaki Mitsuya, Prasanth Reddy Nyalapatla
  • Tricyclic P2-ligand containing potent HIV-protease inhibitors against HIV/AIDS
    Patent number: 11028096
    Abstract: Various embodiments relate to a compound of the formula (I) and (II), wherein X, X1, X2, X3, and R1-R4 are defined herein, as well as pharmaceutical compositions comprising compounds of the formula (I) and/or (II) and methods of treating an HIV infection comprising administering a therapeutically effective amount of one or more compounds of formula (I) and/or (II), or a pharmaceutical composition comprising compounds of the formula (I) and/or (II), to a patient in need thereof.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: June 8, 2021
    Assignee: Purdue Research Foundation
    Inventors: Arun K. Ghosh, Hiroaki Mitsuya, Prasanth Reddy Nyalapatla
  • TRICYCLIC P2-LIGAND CONTAINING POTENT HIV-PROTEASE INHIBITORS AGAINST HIV/AIDS
    Publication number: 20190359626
    Abstract: Various embodiments relate to a compound of the formula (I) and (II), wherein X, X1, X2, X3, and R1-R4 are defined herein, as well as pharmaceutical compositions comprising compounds of the formula (I) and/or (II) and methods of treating an HIV infection comprising administering a therapeutically effective amount of one or more compounds of formula (I) and/or (II), or a pharmaceutical composition comprising compounds of the formula (I) and/or (II), to a patient in need thereof.
    Type: Application
    Filed: November 9, 2017
    Publication date: November 28, 2019
    Inventors: Arun K. Ghosh, Hiroaki Mitsuya, Prasanth Reddy Nyalapatla